P-selectin targeting ligand and compositions thereof

Details P-selectin targeting ligand and compositions thereof P-selectin targeting ligand and compositions thereof

2011-08-23

2011-08-23

Audet, Maury (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S300000, C424S001690

Reexamination Certificate

active

08003596

ABSTRACT:
P-selectin targeting ligand molecules are provided as well as compositions, including kits, which comprise such P-selectin targeting ligand molecules, such composition being useful for use as pharmaceutical formulations which can be administered safely and effectively and as diagnostic formulations.

REFERENCES:
patent: 6583301 (2003-06-01), Eaton et al.
patent: 1 288 222 (2003-03-01), None
patent: 99/52858 (1999-10-01), None
patent: 01/12154 (2001-02-01), None
patent: 01/60416 (2001-08-01), None
patent: 02/26776 (2002-04-01), None
patent: 02/055111 (2002-07-01), None
patent: 02/098951 (2002-12-01), None
patent: WO 02/098952 (2002-12-01), None
patent: 03/020753 (2003-03-01), None
Molenaar et al. Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists. Blood (2002), 100(10), 3570-3577.
International Preliminary Examination Report on Patentability for PCT/EP2004/005873 dated Dec. 1, 2005.
Geng, J. et al., “Lectin Domain Peptides from Selectins Interact with Both Cell Surface LigandS and Ca2+ Ions”,The Journal of Biological Chemistry,1992, vol. 267, No. 28, Issue of Oct. 5, pp. 19846-19853.
Chamoun, F. et al., “Pathophysiologic Role of Selectins and Their Ligands in Ischemia Reperfusion Injury”,Frontiers in Bioscience 5,Nov. 1, 2000, pp. 103-109.
Everts, M. et al., “Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate”,The Journal of Immunology,2002, vol. 168, pp. 883-889.
Hayashi, S. et al., “Roles of P-Selectin in Inflammation, Neointimal Formation, and Vascular Remodeling in Balloon-Injured Rat Carotid Arteries”,Circulation,2000, vol. 102, pp. 1710-1717.
Maruyama, K., “PEG-Immunoliposome”,Bioscience Reports,Apr. 2002, vol. 22, No. 2, pp. 251-266.
Spragg, D. et al., “Immunotargeting of Liposomes to Activated Vascular Endothelial Cells: A Strategy for Site-Selective Delivery in the Cardiovascular System”,Proc. Natl. Acad. Sci.USA, Aug. 1997, vol. 94, pp. 8795-8800.
Panés, J., “Adhesion Molecules in Inflammatory Bowel Disease”,Pathophysiology 5,1999, 271-282.

Affiliated with

Also associated with

Rating

P-selectin targeting ligand and compositions thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with P-selectin targeting ligand and compositions thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P-selectin targeting ligand and compositions thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2655912